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Abstract
Background: Attention has shifted to the use of non-pharmacological interventions to prevent cognitive decline as
a preventive strategy, as well as for those at risk and those with mild cognitive impairment. Early introduction of
psycho-social interventions can address cognitive decline and significantly impact quality of life and the wellbeing
of elderly individuals. This pilot study explores the feasibility of using art therapy and music reminiscence activity to
improve the cognition of community living elderly with mild cognitive impairment.
Methods/Design: This open-label, interventional study involves a parallel randomized controlled trial design with
three arms (two intervention arms and a control group) over a nine-month period. Participants will be community-
living elderly individuals aged 60–85 years, both genders, who meet predefined inclusion and exclusion criteria. In
the initial three months, interventions will be provided weekly and for the remaining six months fortnightly. A
sample size of 90 participants is targeted based on expected neuropsychological test performance, a primary
outcome measure, and drop-out rates. The randomization procedure will be carried out via a web-based
randomization system. Interventions will be provided by trained staff with a control group not receiving any
intervention but continuing life as usual. Assessments will be done at baseline, three months, and nine months, and
include neuroimaging to measure cerebral changes and neuropsychological tests to measure for changes in
cognition. Secondary outcome measures will include mood changes in anxiety and depression and telomere
lengths. Statistical analysis will be undertaken by statisticians; all efficacy analysis will be carried out on an intention-
to-treat basis. Primary and secondary outcomes will be modeled using the linear mixed model for repeated
measurements and further analysis may be undertaken to adjust for potential confounders.
Discussion: This will be the first study to compare the effectiveness of art therapy and music reminiscence activity
in a randomized controlled trial. We expect that the trial will provide useful evidence for developing psychosocial
interventions for the elderly with mild cognitive impairment.
Trial registration: The study was registered on 7 July 2016 at Clinical Trials.gov, a service of the US National
Institute of Health (NCT02854085), retrospectively.
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Background
Population aging is a global public health concern and
dementia is one of the major causes of disability and de-
pendency in the elderly population worldwide [1]. Re-
search now targets the prevention or delay of cognitive
decline as a more beneficial approach and attention has
shifted to non-pharmacological interventions and pre-
ventive strategies for cognitively normal elderly and
those exhibiting mild cognitive problems.
Mild cognitive impairment (MCI, DSM-5 Minor Neuro-
cognitive Disorder) [2] is associated with high burden with
about 50% of individuals going on to develop dementia
within five years. While 14–40% may return to normal
cognitive functioning over time, others may exhibit a per-
sistent form of MCI without conversion [3, 4]. Interven-
tions from stimulating leisure activities and an active
cognitive lifestyle to address cognitive decline at this stage,
have a significant impact on the quality of life and well-
being of elderly individuals and also illness progression
[5]. Evidence suggests that the causes of aging are multi-
factorial, ranging from increased inflammation and oxida-
tive stress to decreased mitochondrial function, hormonal
levels, and genome instability [6]. However, the aging
brain still exhibits plasticity which allows interventions
and cognitive training to bring about alterations in cere-
bral morphology and function [7].
A systematic review of psycho-social interventions (69
prospective controlled trials) found positive effects on
quality of life and positive mental health [8] and engaging
in stimulating activities at least twice a week reduced the
risk of dementia by 50% [9]. Interventions focusing mainly
on lifestyle modifications, notably the FINGER trial, have
reported significant benefits from a multifaceted interven-
tion that included diet, exercise, cognitive training, and
vascular monitoring [10].
Our earlier work in an open-label trial of art therapy
(AT), music reminiscence, mindfulness practice, and Tai
Chi exercise with community-living elderly, revealed
improvements in sub-syndromal anxiety and depressive
symptoms [11]. This was followed by a randomized con-
trolled trial (RCT) to examine Mindfulness Awareness
Practice (the control group received Health Education) in
the elderly with MCI and designed with a nine-month
duration deemed sufficient for intervention response [12].
Interventions were provided weekly for three months and
then monthly for six months and a range of “psychobio-
markers” were investigated [13].
Telomere length was one of those measured as it is widely
accepted as a biomarker for cellular aging and cognitive de-
cline with changes from various activities resulting in longer
telomeres [14–16]. Preliminary findings from the Mindful-
ness Awareness Practice RCT have revealed changes in func-
tional brain activity, neuropsychological tests, telomere
lengths, and oxidative stress markers after just three months
of weekly intervention (manuscript in preparation). Import-
antly, the frequency of the activity had a significant impact
on the sustainability of gains produced by the intervention
[17]. Existing research on AT and music reminiscence activ-
ity (MRA), however, is limited, especially on the efficacy of
these interventions on cognition. Kim has shown that AT
improves mood and overall wellbeing of elderly individuals,
but the cognitive status of the participants was unknown
[18]. While Alders and Levine-Madori have results that seem
to suggest that AT is useful in improving cognitive perform-
ance [19], the study methodology was not rigorous. The ex-
perimental group could choose the activity to participate in
and could attend as few as three of the ten AT sessions. The
study by Rusted et al. [20] did not clearly explain the control
group activity and recruited a wide range of dementia partic-
ipants. None of the studies have been of sufficient rigor or
focused on elderly with MCI.
Listening to music effectively stimulates the auditory
cortex and other brain areas related to attention, semantic
processing, memory, motor function, and emotional pro-
cessing [21]. Yet studies on the specific use of MRA and its
efficacy for elderly with MCI are rare. Most of the research
has examined music therapy, with components of reminis-
cence, for mood symptoms, where listening to music they
preferred [22] and choosing the type of music to listen to
reduced anxiety and depression in the elderly [23, 24].
Petrovsky et al. did a review of the utility of music interven-
tions on mood in the elderly with mild dementia and found
that many of the studies were not methodologically strong,
indicating that the evidence was inconclusive [25].
The research on music therapy and cognitive changes
however has shown positive improvements on Mini-
Mental State Examination (MMSE) scores, even one
month post intervention [24] and on the short-term for
working memory and quality of life in elderly with mild
or moderate dementia [26]. However, the efficacy of
music therapy for cognitive improvement is still debated
and there is a gap in the literature for music reminis-
cence activities in elderly with MCI.
Methods/Design
Aims of study
This pilot study aims to explore the feasibility of using
AT and MRA to improve the cognition of community
living elderly with MCI (Diagnostic and Statistical
Manual-5: Mild Neurocognitive Disorder) [2].
The primary outcomes will be the structural cerebral
changes that occur with the two interventions and the
extent to which the therapies may reverse cognitive
impairment and/or prevent further cognitive decline on
neuropsychological tests of cognition. This will be based on
participants’ pre-, three-month and nine-month neuro-
psychological test scores, compared with individuals in the
control arm who do not participate in active interventions.
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Secondary outcomes comprise changes in blood bio-
markers, psychological wellbeing, and mood symptoms.
We hypothesize that participants in both active inter-
vention arms will have (1) improved functional connect-
ivity, (2) improved neuropsychological cognitive test
scores, (3) increased telomere lengths, and (4) enhanced
psychological wellbeing and reductions in anxiety and
depressive symptoms compared with the control group.
No a priori hypotheses were developed as to whether AT
or MRA is more effective as the comparison is exploratory.
Study design
This is an open-label, interventional study involving a par-
allel RCT design with three arms and run over nine
months. The duration of nine months was used in previ-
ous RCTs of psychosocial interventions at our center and
provided a trial length of sufficient duration which yielded
measurable changes. The protocol was prepared according
to the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guidelines (see Fig. 1,
Additional file 1, and Fig. 2). Interventions will be weekly
for the first three months, then fortnightly for the
remaining six months. Weekly interventions provide
greater practice effects and improvements in cognition
and brain function, if any, can be detected by three
months. In the subsequent six months, the frequency of
the interventions has been increased to fortnightly, based
on previous trial experience that monthly interventions do
not sustain the early gains. Study evaluations will be done
by comparing the two intervention groups (AT and MRA)
and a control group. Participants will have written in-
formed consent taken, screening, and baseline measures
completed before randomization into one of the three
study arms.
Intervention Arm 1: Participants will receive AT
Intervention Arm 2: Participants will receive MRA
Control Arm: Participants will not receive any inter-
vention but continue their life as usual.
Eligibility criteria
The inclusion criteria are:
1. Aged 60–85 years, both genders, and living in the
community and fulfils the operational definition/
criteria of MCI: (a) at least one age-education
adjusted neuropsychological test Z score < −1.5; (b)
do not meet DSM V criteria for a major neurocogni-
tive disorder; (c) memory/cognitive complaint
preferably corroborated by a reliable informant;
2. Functions independently as assessed with Barthel’s
Activities of Daily Living and instrumental Activities
of Daily Living;
3. Able to travel to the data collection site on their
own and participate in the activity weekly for
12 weeks and then fortnightly for six months.
The exclusion criteria are:
1. Those who do not meet the above inclusion criteria
(i.e. do not have MCI diagnosis);
2. Those with dementia/major neurocognitive disorder
or normal aging;
3. Presence of a neurological condition, e.g. epilepsy,
Parkinson’s disease, stroke;
4. Presence of a major psychiatric disorder, e.g. major
depression, psychoses;
5. Terminal illness, e.g. cancer;
6. Presence of significant visual and/or hearing
impairment and color blindness;
7. Participants in another intervention study at the
same time.
Randomization procedure
Participants will be randomized (on the same day after
taking written informed consent, screening, and com-
pleting baseline measures) to the AT, MRA, or control
groups at a 1:1:1 allocation ratio. Balanced intervention
assignments will be achieved using permuted block
randomization stratified by gender. Block size will be
determined by the statistician responsible for generating
the randomization list and will not be made known to
the clinical investigator or site personnel.
Consent taking, screening and 
eligibility criteria
Demography questionnaire, basic health 
screen, functional assessment, 
neuropsychological tests, neuroimaging 
and blood investigations
Baseline
Pre-baseline
12x 
Weekly 
sessions
Art/Music 
interventions
Life as 
Usual Controls
9 Months
(End)
Basic health screen (excluding 
height), functional assessment, 
neuropsychological tests and 
blood investigations
Basic health screen (excluding height), 
functional assessment, neuropsychological 
tests and neuroimaging. Only Art/Music 
interventions undergo blood investigations
3 Months
12x 
Fortnightly 
sessions
Life as 
Usual ControlsArt/Music 
interventions
Fig. 1 Workflow plan for participants
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Implementation of the randomization process will be
carried out via a web-based randomization system by
Singapore Clinical Research Institute. The randomization
system will then determine the intervention arm and
provide a unique participation number to be used for the
participant.
Delivery of interventions
The interventions will be delivered by trained art and
music therapists. Activities in each intervention is struc-
tured and planned for the whole study period.
Art therapy
The AT activity was developed by the team in consultation
with art therapists. It will have two components: creation
of art pieces; and viewing and discussing art pieces with
narration of thoughts and inner experiences. Studies have
shown that visual art production interventions and cogni-
tive art evaluation groups benefit the individual but in
slightly different ways [27]. Hence, this study will include
both activities and consider them as one intervention.
The guided viewing and making of visual images and
talk therapy with an art therapist contributes to
externalization of thoughts and feelings which may
otherwise remain unexpressed. Each weekly session will
begin with mindful relaxation to help the participants
focus on the task ahead. They will be asked to draw any-
thing they want or what they think is relevant to the
topic for each session. They will then be asked to share
about the picture they have created, feelings, and per-
spectives, first in pairs and then with the group where
image appreciation activities will be used to help partici-
pants gain insights and discuss their feelings.
In addition, participants will visit both the National
Art Gallery and the National University of Singapore Art
Museum once a month in the first three months. They
will view displayed artworks in guided sessions and will
be invited to share their views and feelings about the
Fig. 2 Standard Protocol Items: Recommendation for Interventional Trials (SPIRIT) figure: the schedule of enrolment, interventions, and
assessments. M months, VAS visual analog scale, ADL Barthel Index (Activities of Daily Living), iADL instrumental Activities of Daily Living, PDQ
Perceived Deficits Questionnaire, MMSE Mini-Mental State Examination, CDR Clinical Dementia Rating, GDS-15 Geriatric Depression Scale (15-item),
GAI-20 Geriatric Anxiety Inventory, fMRI functional magnetic resonance imaging, ZBI Zarit Burden Inventory
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artefacts. Each of the AT sessions will last 1 h (inclusive
of 5 min of mindful relaxation and a 15-min break).
From the fourth to ninth month, fortnightly AT sessions
are provided with sessions at the study center alternating
with sessions at the National Art Gallery or National Uni-
versity of Singapore Art Museum. Participants will visit
the Art Gallery and Art Museum, first, because the art
pieces cannot be removed from these places and brought
to the research center; second, two sites are involved
because neither one of the sites has sufficient docents to
manage the number of visits alone. With two sites, each
site will host the participants’ visit only once a month in
the first three months and then in alternate months for
the next six months. Participants will be taken to the Art
Gallery and Museum by coach and will be accompanied
by research staff during the 15-min journey.
Content of the art therapy intervention
Weekly sessions:
Session 1: Art and expression
Session 2: Friendship
Session 3: Visit to the NUS Art Museum
Session 4: Visit to the National Art Gallery
Session 5: Emotions and feelings
Session 6: Family
Session 7: Visit to the NUS Art Museum
Session 8: Visit to the National Art Gallery
Session 9: Happiness
Session 10: Hopes and wishes
Session 11: Visit to the NUS Art Museum
Session 12: Visit to the National Art Gallery
Fortnightly sessions:
Session 13: Art activity
Session 14: Visit to the NUS Art Museum
Session 15: Art activity
Session 16: Visit to the National Art Gallery
Session 17: Art activity
Session 18: Visit to the NUS Art Museum
Session 19: Art activity
Session 20: Visit to the National Art Gallery
Session 21: Art activity
Session 22: Visit to the NUS Art Museum
Session 23: Art activity
Session 24: Visit to the National Art Gallery
Music reminiscence activity
Reminiscence therapy with music entails listening and
discussing activities, events, and experiences related to
the music. Sessions will be presented as music videos,
with additional prompts in the form of photographs, to
facilitate therapy. Participants who agree will be asked to
bring 10–20 photographs and also choose songs or
music for the videos. Reminiscence provokes shared feel-
ings and boosts self-esteem while the group process pro-
vides validation for each member [28]. The structured
activity was previously planned by the team and used ef-
fectively in the earlier naturalistic study [11]. Participants
will meet weekly for the first three months and then
fortnightly for six months. As in the AT intervention
group, each session will begin with a 5-min mindful re-
laxation and the 1-h session will include a 15-min break.
Content of the music reminiscence activity
Weekly sessions:
Session 1: Introduction and ice-breaking session
Session 2: Family of origin
Session 3: House/Place I grew up in
Session 4: Childhood
Session 5: Childhood games
Session 6: School
Session 7: My favorite teacher, subject, classmate
Session 8: Occupation
Session 9: Significant events/achievements
Session 10: Friendships
Session 11: My best friend
Session 12: Family/Marriage
Fortnightly sessions:
Session 13: Parents/Children
Session 14; Hobbies, sports and games
Session 15: Holidays and travel
Session 16: My favorite place in Singapore
Session 17: Favorite food
Session 18: Memorable songs
Session 19: Festivals
Session 20: Famous actors/singers
Session 21: Recreational places
Session 22: Old movies
Session 23: Favorite parks
Session 24: Termination; group discussion
Control group
The control group will not receive any intervention but
continue their life as usual.
Study setting
Data collection will be done by trained nurses and research
assistants blinded to the group assignment at a community
research center used by the university, named the Training
and Research Academy at Jurong Point (TaRA@JP).
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Measures
A questionnaire on demography will include a basic health
screen (weight, height, BP, and PR at baseline and repeated
[with the exception of height] at three and nine months).
Functional assessment will be done using the Activities of
Daily Living (ADL) questionnaire and the instrumental
ADL (iADL).
Subjective cognitive impairment will be assessed using
the Perceived Deficits Questionnaire (PDQ). It consists
of 20 questions answered on a five-point Likert scale.
Scores range from 0 to 80, with higher scores indicating
severe impairment.
Cognitive assessments will be done with the following
validated assessment scales:
(1)Mini-Mental State Examination (MMSE), a brief
30-point questionnaire, will be used to screen for
cognitive impairment. Scores range from 0 to 30,
with higher scores indicating less impairment;
(2)Clinical Dementia Rating (CDR) Scale is a five-point
scale used to characterize six domains of cognitive
and functional performance applicable to
Alzheimer’s disease and other dementias: memory,
orientation, judgment and problem-solving, commu-
nity affairs, home and hobbies, and personal care;
(3)Neuropsychological tests:
(a)Rey Auditory Verbal Learning Test (RAVLT)
evaluates declarative verbal learning and memory;
(b)Digit Span Task consists of a Digit Span Forward
(DSF) and Digit Span Backward (DSB) and is used
to assess attention and verbal working memory;
(c)Color Trails Test (CTT) 1 and 2 assess sustained
attention and memory;
(d)Block Design, a subtest of the Wechsler
Intelligence Tests, measures visual–spatial and
organizational processing abilities and non-verbal
problem-solving skills.
Psychological wellbeing assessment will be assessed
with the:
(1)Geriatric Depression Scale (GDS): a 15-item “yes/
no” questionnaire with higher total scores associated
with higher risk of depression;
(2)Geriatric Anxiety Inventory (GAI): a 20-item “agree/
disagree” questionnaire measuring dimensional
anxiety, with higher total scores associated with
anxiety symptoms.
Participants with high GDS score (≥5) and/or high
GAI score (≥ 10) will be clinically assessed using the
Structured Clinical Interview for DSM Disorder (SCID)
to rule out major psychiatric disorders (e.g. generalized
anxiety disorder or major depressive disorder).
Neuroimaging assessment of functional connectivity and
structure of the brain
Functional magnetic resonance imaging (fMRI) will be
employed to examine changes in functional connectivity.
Images will be acquired on a 3 T Siemens scanner using
a standard Siemens whole head coil. Twenty-eight axial
slices (4-mm thick, 1-mm skip) parallel to the plane
connecting the anterior and posterior commissures and
covering the whole brain will be imaged using a T2*-
weighted gradient echo spiral pulse sequence (repetition
time/echo time = 2000/30 ms; flip angle = 80°; and inter-
leave = 1). The field of view will be 200 × 200 mm2 and
the matrix size 64 × 64, yielding an in-plane isotropic
spatial resolution of 3.125 mm. An automated high-
order shimming method based on spiral acquisitions will
be used before acquiring fMRI scans. All participants
will undergo the task-free fMRI scan after being
instructed only to remain awake with their eyes closed.
White matter diffusion tractography imaging (DTI)
will be utilized to identify anatomical connections be-
tween functionally correlated regions. Anatomic T1-
weighted scans will be obtained on a 3 T Siemens scan-
ner with the following parameters: repetition time =
2100 ms; flip angle = 12°; slice thickness = 1.5 mm; inver-
sion time = 1100 ms; matrix = 192 × 256; field of view =
172.5 mm; echo time = 3.87 ms. The DTI will be ac-
quired in one non-weighted and six diffusion-weighted
non-collinear directions with an echo-planner sequence
with diffusion weighting 9b value of 1000 smm−1. A dual
spin echo will be used to minimize distortion due to
eddy currents. Imaging parameters are: repetition time =
6100 ms; flip angle = 90°; field of view = 178 × 219;
matrix = 104 × 128; voxel size = 1.71 × 1.71. × 4 mm;
number of averages = 4; echo time = 92 ms.
The control group will do baseline questionnaires and
investigations similar to participants in the two interven-
tion arms. They will do the neuroimaging at baseline
and three months as well as the other investigations,
similar to those in the two intervention arms. The only
difference is the control group will not have blood sam-
ples taken at three months.
The fMRI scanning will be task-free. It is non-invasive
and does not involve any injection of tracer dyes.
Caregivers will be asked to complete the Zarit Burden
Scale at baseline, three months, and nine months. This
is optional and caregivers can choose not to complete
this scale and this will have no impact on subject partici-
pation. Caregivers will be asked to complete a portion of
the Clinical Dementia Rating at baseline (if they are
present or available) (Fig. 2).
Recruitment
Participants will be recruited from amongst elderly indi-
viduals living around TaRA@JP and known to the research
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center. Only participants who agreed to be contacted for
future research and known to have early cognitive impair-
ment will be contacted by phone and invited to participate
in the current study.
Others who have heard about the study will be re-
cruited if they meet inclusion criteria and reside within
close proximity to the research site (TaRA@JP) for travel
arrangements.
They will be informed of the study and provided with a
copy of the invitation letter and participant information
sheet – both English and Mandarin versions will be made
available to them. They will be given time to read the
document in a private area at TaRA@JP and given time to
consider whether to agree to participate in the study.
Nurses will interpret orally for those who are illiterate
and for those who do not understand English. A Short
Consent Form (Mandarin) will be used for the partici-
pant’s signature (or thumb print) and an impartial wit-
ness will be present and sign the document as well. If a
translator is involved in the consent taking, he/she will
also sign the consent form.
Outcomes
Primary outcome measures:
1. Improvements in neuropsychological test scores at
three months and nine months;
2. Positive changes in cerebral functioning at three
months.
Secondary outcome measures:
1. Improvement in GDS and GAI scores at three
months and nine months;
2. Increase in telomere lengths at three months and
nine months.
Sample size justification
To obtain the confidence interval with the width of 1
standard deviation (SD), which has a 90% chance to
include the true difference of mean change in neuro-
psychological test score at three months between the
intervention and control groups, requires 22 participants
in each group. By considering the 25% drop-out rate, 30
participants will be required in each group. Thus, the total
sample size will be 90 participants (30 in the AT interven-
tion group, 30 in MRA, and 30 in the control group).
Assessments and visit schedule
Pre-baseline
Screening, consent taking, and eligibility criteria are
checked. Those with high GDS/GAI scores will go through
a SCID examination to evaluate the presence of a major
psychiatric disorder. This will be done by psychiatrists in
the study team who have been trained to do this examin-
ation. Any participants found to have a psychiatric disorder
through the SCID examination will be referred for follow-
up by a medical professional. A standard referral letter has
been prepared.
Baseline
Demography questionnaire, basic health screen, func-
tional assessment, neuropsychological tests, neuroimag-
ing, and blood investigations are carried out.
Three months
Basic health screen (excluding height), functional assess-
ment, neuropsychological tests, neuroimaging, and blood
investigations are repeated.
Nine months (study end)
Basic health screen (excluding height), functional assess-
ment, neuropsychological tests, and blood investigations
are repeated.
The time taken for the health screening, completion of
the demographic data, main questionnaire, and blood
sample collection will take about 1 h.
The neuropsychological tests will take about 1 h 45 min.
The baseline visit to TaRA@JP will take about 3 h. Subse-
quent visits at three months and nine months will take 2 h.
The fMRI scans will be conducted at CIRC in NUS
and the appointment will be on another day. The im-
aging sessions will take 1 h. However, the time within
the scanner is about 45 min.
See Tables 1 and 2 for the visit schedules for the inter-
ventions and control groups, respectively.
Blood samples (3 mL) will be collected at three time-
points for those in the AT and MRA arms (baseline,
three months, nine months) for telomere lengths. For
the control group, it will be done twice, at baseline and
at nine months.
Samples will be stored immediately in a mini-fridge
(4 °C) at TaRA@JP and transported within 12 h of col-
lection to the labs.
Risks and safety monitoring
Risks include some pain and bruising during blood sam-
pling. To minimize risks associated with the blood, sam-
pling only one venipuncture will be performed at each of
the three time-points and blood will be collected using
vacutainers. Trained nurses will perform the procedure.
Some may experience some discomfort from the noise
and the enclosed space within the scanner. Participants
will be informed about the noise and ear plugs will be
provided. If the noise is intolerable and the participant
wishes to discontinue with the scanning, the scanning
will be stopped.
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Data management
Data forms will be coded with a study number (starting
with 001). Data will be entered and stored on a standa-
lone computer and the information will be password
protected. Only the principal investigator, investigators,
and study coordinator in the project will have access to
the data for analysis. In accordance with NUS data man-
agement policy (DPRT-2011-04), data will be kept for
ten years after the research is completed and all data
(electronic and hard copy) will be destroyed after the
storage period.
The investigators and the trial coordinators will monitor
that the informed consent process is conducted appropri-
ately and that informed consent was obtained prior to
proceeding with any study procedures. Only participants
who meet study eligibility criteria will be enrolled.
Participants’ data will be identified only by a study num-
ber. Only the principal investigator will have access to
identifiers that can link the data to the individual partici-
pant. De-identified data will be collected and analyzed as
specified in the protocol. Participants who drop out will
be noted and their reasons documented. Primary and
secondary end-points will be reviewed to ensure data are
correctly entered and meet protocol requirements.
Statistical analyses
All efficacy analyses will be carried out on an intention-to-
treat (ITT) basis. That is, all randomized participants will
be included in the analysis and the intervention group of
participants will be according to the randomization list
planned prior to the intervention commencement.
The primary outcomes – neuropsychological test
scores – at baseline, three months, and nine months will
be modeled using the linear mixed model for repeated
measurements. Differences in the estimated means of
the changes at three and nine months from baseline
between the intervention and control groups and their
associated 90% and 95% confidence intervals will be
calculated. Further, analysis may be performed to
adjust the model for potential confounders, such as
age, gender, and education level. Secondary outcomes
(cerebral functioning, the GDS and GAI scores, and
telomere lengths) will be analyzed similar to the pri-
mary outcomes.
Demographic and other baseline characteristics and
reported adverse events and serious adverse events will
be summarized using descriptive statistics.
Discussion
Art and music activities have been described as “empow-
ering tools that can assist in the aging process” [29]. Evi-
dence suggests that training in these areas strengthen
attention systems and improve cognition. However, the
research to date is still limited on the effectiveness of
incorporating these activities as part of care plans for
the elderly with cognitive impairment. Furthermore, it is
unlikely that these activities will “always improve general
cognition” [30]. This study will more systematically de-
termine whether both these activities will be of benefit
for elderly with mild cognitive impairment and will
provide additional psychosocial interventions that will
be of use to this group.
Trial status at the time of manuscript submission
The recruitment commenced in 13 June 2016 and the
trial will end in April 2017.
Additional file
Additional file 1: SPIRIT Checklist. Recommended items to address in a
clinical trial protocol and related documents. (PDF 122 kb)
Table 1 Visit schedule for intervention arms
Pre-baseline/Baseline Three months Nine months
(study end)
Informed consent
process
Main questionnaire Main questionnaire
Eligibility screening Neuropsychological
tests
Neuropsychological
tests
Demographic data MRI scan Clinical Dementia
Rating
Main questionnaire Weight, vital Signs Weight, vital signs
Neuropsychological
tests
Blood sample
collection
Blood sample
collection
Clinical Dementia
Rating
MRI scan
Basic health screen
Blood sample
collection
Table 2 Visit schedule for controls
Pre-baseline/Baseline Three months Nine months
(study end)
Informed consent process Main questionnaire Main questionnaire
Eligibility screening Neuropsychological
tests
Neuropsychological
tests
Main questionnaire MRI scan Clinical Dementia
Rating
Demographic data Weight, vital signs Weight, vital signs
Neuropsychological
tests
Blood sample
collection
Clinical Dementia Rating
MRI scan
Basic health screen
Blood sample collection
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